Skip to main content
Go Back to System Level
  1. Levitt DL, Mesmar B, Munir KM. Renal Transplant-Associated Thyroid Tuberculosis. J Endocr Soc. May 1 2017;1(5):553-559
  2. Mesmar B, Poola-Kella S, Malek R. THE PHYSIOLOGY BEHIND DIABETES MELLITUS IN PATIENTS WITH PHEOCHROMOCYTOMA: A REVIEW OF THE LITERATURE. Endocr Pract. Aug 2017;23(8):999-1005.
  3. Frunza-Stefan S, Poola-Kella S, Silver K. Non-uraemic calciphylaxis (NUC) post liver transplantation. BMJ Case Rep. Oct 24 2018;2018. 
  4. Frunza-Stefan S, Whitlatch HB, Rao GG, Malek R. Unusual case of anti-N-methyl-D-aspartic acid-receptor (NMDA-R) encephalitis and autoimmune polyglandular syndrome (APS). BMJ Case Rep. May 2 2018;2018. 
  5. Levitt DL, Spanakis EK, Ryan KA, Silver KD. Insulin Pump and Continuous Glucose Monitor Initiation in Hospitalized Patients with Type 2 Diabetes Mellitus. Diabetes Technol Ther. Jan 2018;20(1):32-38. 
  6. Miller A, Brooks LK, Poola-Kella S, Malek R. Posaconazole-Induced Adrenal Insufficiency in a Case of Chronic Myelomonocytic Leukemia. Case Rep Endocrinol. 2018;2018:2170484. 
  7. Poola-Kella S, Steinman RA, Mesmar B, Malek R. Gestational Diabetes Mellitus: Post-partum Risk and Follow Up. Rev Recent Clin Trials. Jan 31 2018;13(1):5-14. 
  8. Satyarengga M, Siddiqui T, Spanakis EK. Designing the Glucose Telemetry for Hospital Management: From Bedside to the Nursing Station. Curr Diab Rep. Aug 29 2018;18(10):87. 
  9. Spanakis EK, Levitt DL, Siddiqui T, et al. The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System. J Diabetes Sci Technol. Jan 2018;12(1):20-25. 
  10. Brooks LK, Kalyanaraman N, Malek R. Diabetes Care for Patients Experiencing Homelessness: Beyond Metformin and Sulfonylureas. Am J Med. Apr 2019;132(4):408-412. doi:10.1016/j.amjmed.2018.10.033.
  11. Memon R, Malek R, Munir KM. Doubling of Hemoglobin A1c on PCSK9 Inhibitor Therapy. Am J Med. Jan 2019;132(1):e17-e18. 
  12. Miller A, Silver KD. Thyroid Storm with Multiorgan Failure Treated with Plasmapheresis. Case Rep Endocrinol. 2019;2019:2475843. 
  13. Rahman W, Solinsky PJ, Munir KM, Lamos EM. Pharmacoeconomic evaluation of sodium-glucose transporter-2 (SGLT2) inhibitors for the treatment of type 2 diabetes. Expert Opin Pharmacother. Feb 2019;20(2):151-161. 
  14. Satyarengga M, Silver KD. Severe hypercalcaemia due to household cleaner ingestion. BMJ Case Rep. Oct 30 2019;12(10). 
  15. Mesmar B, Kristan M, Satyarengga M, Lamos EM, Malek R, Munir KM. The use of diazoxide in the management of spontaneous hypoglycemia in patients with ESRD. CEN Case Rep. Aug 2020;9(3):271-277. 
  16. Migdal AL, Spanakis EK, Galindo RJ, et al. Accuracy and Precision of Continuous Glucose Monitoring in Hospitalized Patients Undergoing Radiology Procedures. J Diabetes Sci Technol. Nov 2020;14(6):1135-1136. 
  17. Rahman W, Conley A, Silver KD. Atezolizumab-induced type 1 diabetes mellitus in a patient with metastatic renal cell carcinoma. BMJ Case Rep. Jul 2 2020;13(7) 
  18. Singh LG, Levitt DL, Satyarengga M, et al. Continuous Glucose Monitoring in General Wards for Prevention of Hypoglycemia: Results From the Glucose Telemetry System Pilot Study. J Diabetes Sci Technol. Jul 2020;14(4):783-790. 
  19. Singh LG, Satyarengga M, Marcano I, et al. Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose Monitoring: The Glucose Telemetry System, a Randomized Clinical Trial. Diabetes Care. Nov 2020;43(11):2736-2743. 
  20. Davis GM, Spanakis EK, Migdal AL, et al. Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients With Diabetes. Diabetes Care. Jul 2021;44(7):1641-1646. 
  21. Elsamadicy EA, Yazdani S, Karuppiah A, et al. Paraganglioma Presenting as Hypoxia and Syncope in Pregnancy: A Case Report. A A Pract. Mar 8 2021;15(3):e01411. 
  22. Kim DW, Miller A, Li A, Hardy N, Silver KD. Hypercalcemia of Malignancy: Simultaneous Elevation in Parathyroid Hormone-Related Peptide and 1,25 Dihydroxyvitamin D in Sarcoma. AACE Clin Case Rep. May-Jun 2021;7(3):169-173. 
  23. Kristan MM, Kim YK, Nelson T, et al. Predictors of Severe COVID-19 in Patients With Diabetes: A Multicenter Review. Endocr Pract. Aug 2021;27(8):842-849. 
  24. Lamos EM, Kristan M, Siamashvili M, Davis SN. Effects of anti-diabetic treatments in type 2 diabetes and fatty liver disease. Expert Rev Clin Pharmacol. Jul 2021;14(7):837-852. 
  25. Memon R, Levitt D, Salgado Nunez Del Prado SR, Munir K, Lamos E. Knowledge of Hemoglobin A1c and Glycemic Control in an Urban Population. Cureus. Mar 19 2021;13(3):e13995. 
  26. Memon R, Salgado Nunez Del Prado SR, Lamos EM, et al. Biochemical follow-up of nonfunctioning benign thyroid nodules. Clin Endocrinol (Oxf). Feb 2021;94(2):322-329. 
  27. Rao VP, Satyarengga M, Lamos EM, Munir KM. The Use of Transcutaneous Magnetic Stimulation to Treat Painful Diabetic Neuropathy. J Diabetes Sci Technol. Nov 2021;15(6):1406-1407. 
  28. Gothong C, Singh LG, Satyarengga M, Spanakis EK. Continuous glucose monitoring in the hospital: an update in the era of COVID-19. Curr Opin Endocrinol Diabetes Obes. Feb 1 2022;29(1):1-9. 
  29. Vasiloglou MF, Marcano I, Lizama S, Papathanail I, Spanakis EK, Mougiakakou S. Multimedia Data-Based Mobile Applications for Dietary Assessment. J Diabetes Sci Technol. Mar 29 2022:19322968221085026. 

In This Section: